What is Leerink Partnrs’ Forecast for KROS Q2 Earnings?
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Keros Therapeutics in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst T. Smith expects that the company will post earnings per share of ($1.02) for the quarter. […]
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Keros Therapeutics in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst T. Smith expects that the company will post earnings per share of ($1.02) for the quarter. […]
